EDGAR Filing Documents for 0001193125-21-089692

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001193125-21-089692

Filing Date

2021-03-22

Accepted

2021-03-22 16:55:24

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	d128319d424b3.htm	424B3	959994
2	GRAPHIC	g128319g0322232056824.jpg	GRAPHIC	5367
3	GRAPHIC	g132337g13a30.jpg	GRAPHIC	128992
4	GRAPHIC	g132337g13a40.jpg	GRAPHIC	137639
5	GRAPHIC	g132337g13c77.jpg	GRAPHIC	134877
6	GRAPHIC	g132337g16i22.jpg	GRAPHIC	98342
7	GRAPHIC	g132337g17u63.jpg	GRAPHIC	149564
8	GRAPHIC	g132337g23p99.jpg	GRAPHIC	144075
9	GRAPHIC	g132337g44i44.jpg	GRAPHIC	70932
10	GRAPHIC	g132337g67w31.jpg	GRAPHIC	95674
11	GRAPHIC	g132337g74p07.jpg	GRAPHIC	133689
12	GRAPHIC	g132337g81v00.jpg	GRAPHIC	109571
	Complete submission text file	0001193125-21-089692.txt		2588289

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306

Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676

Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-252589 | Film No.: 21761922
SIC: 2834 Pharmaceutical Preparations